The US Senate just moved to ban Central Bank Digital Currencies until 2030. A 303-page housing bill cleared a key procedural vote 84 to 6 with a provision that The US Senate just moved to ban Central Bank Digital Currencies until 2030. A 303-page housing bill cleared a key procedural vote 84 to 6 with a provision that

Dogecoin Price Prediction for 2026: US Senate Proposes CBDC Ban Until 2030 as Pepeto’s Presale Window Approaches Its Permanent Close at Listing

2026/03/07 08:49
6 min read
For feedback or concerns regarding this content, please contact us at [email protected]

The US Senate just moved to ban Central Bank Digital Currencies until 2030. A 303-page housing bill cleared a key procedural vote 84 to 6 with a provision that defines CBDCs as a threat to personal privacy. This is not a fringe position. This is bipartisan. And for crypto investors, the political sentiment behind it is the most bullish regulatory environment for decentralized assets since the last cycle began.

US Senate advances CBDC ban until 2030 in bipartisan housing legislation as digital dollar faces major political opposition

The US Senate introduced a provision in the 303-page 21st Century ROAD to Housing Act that would prohibit the Federal Reserve from creating a Central Bank Digital Currency until 2030, clearing a procedural vote with 84 to 6 bipartisan support, according to CoinDesk. The measure defines a CBDC as a digital asset denominated in US dollars and available to the public, and exempts private stablecoins that are open, permissionless, and private. Lawmakers cited personal privacy and liberty concerns as the primary rationale. For decentralized crypto markets, a political environment that rejects centralized digital money at the federal level is a fundamental tailwind for assets that offer genuine financial privacy and permissionless transactions.

Dogecoin Price Prediction for 2026: US Senate Proposes CBDC Ban Until 2030 as Pepeto’s Presale Window Approaches Its Permanent Close at Listing

Dogecoin price prediction for 2026 and the presale window that closes permanently at listing

Pepeto: the presale floor at $0.000000186 does not come back after listing and the window is closing now

There is a category of regret in crypto that every long term investor knows. It is not about the tokens they sold too early. It is about the ones they never bought. DOGE at $0.001. PEPE at a fraction of a cent. BTC at $100. In every case, the information was there. The window was open. The price was visible. The only thing missing was the decision.

Pepeto is at $0.000000186 right now. The post listing target is $0.0001. That is 537 times the current price. The PEPE founders are behind it. PepetoSwap is confirmed and approaching launch. The cross chain bridge is announced and close to being ready. The full trading exchange is confirmed by the team and nearing its deployment. Dual audits from SolidProof and Coinsult returned zero vulnerabilities before the presale opened. $7.391 million raised during the most fearful period of this cycle.

Every one of these facts was true before the $7.391 million came in. The investors who moved early read the same information that is available to you right now. Staking at 200% APY rewards holders who commit now. The US Senate’s CBDC ban creates a political environment that is fundamentally favorable to decentralized assets. And the presale floor at $0.000000186 does not reopen after listing. When it closes, it closes permanently. A $4,000 entry becomes $2,148,000 at the 537x target. This is the window.

Dogecoin price prediction: DOGE builds toward $0.105 as monthly chart shows morning doji star

Dogecoin is trading at $0.096 with analysts identifying a morning doji star pattern on its monthly chart, a bullish reversal signal that previously triggered a surge from $0.056 to $0.47, pointing to a 2026 target near $0.105, per CoinMarketCap. Buyers need a daily close above the 20 day EMA at $0.10 to confirm the reversal. If the pattern holds, the path to $0.11 and $0.12 opens. Losing $0.08 risks a slide toward $0.06. The broader CBDC ban news is a fundamental positive for DOGE and the entire meme coin category as political momentum behind decentralized finance grows.

Hyperliquid price prediction 2026: HYPE holds the DeFi DEX lead amid broader market weakness

Hyperliquid is trading at $30.73, maintaining its position as the leading decentralized perpetuals exchange despite broader market weakness. HYPE has gained 8.6 percent over the past seven days while the overall market recovered modestly. The platform recorded $2.2 billion in real world asset trading volume on March 6, representing 30 percent of total daily platform activity. Analysts forecast HYPE could reach $40 to $90 by end of 2026 if the on chain DEX narrative continues to gain institutional adoption. At $30.73, the near term upside from HYPE is meaningful but bounded compared to a presale with 537x still on the table.

The bottom line

The US Senate is banning CBDCs. DOGE is printing a bullish monthly reversal signal. Hyperliquid is building the on chain trading infrastructure of the future. But the window where a $4,000 entry can become $2,148,000 at 537x exists in exactly one place right now, and it closes the moment Pepeto lists. The PEPE founders built $7 billion once without products. Now they have three. The presale is open. It will not be open forever. This is the window.

Click To Visit Pepeto Website To Enter The Presale

FAQs

What is the dogecoin price prediction for 2026 after the US Senate CBDC ban?

The dogecoin price prediction for 2026 after the US Senate CBDC ban points to $0.105 as the near term target from its current price of $0.096, driven by a bullish monthly doji star pattern. The CBDC ban creates a favorable political environment for all decentralized crypto assets. For investors who want higher return potential than DOGE offers, Pepeto at $0.000000186 with a 537x target provides a $4,000 to $2,148,000 opportunity before listing.

What does the US Senate CBDC ban until 2030 mean for crypto investors?

The US Senate CBDC ban until 2030 means that decentralized crypto assets like Dogecoin, Hyperliquid, and Pepeto face a favorable political environment with no government digital dollar competing for the same market. Bipartisan 84 to 6 support signals this is a durable position rather than a partisan issue. Pepeto at $0.000000186 with three DeFi products approaching launch benefits directly from a political environment that favors permissionless financial alternatives.

How does Pepeto compare to Hyperliquid as a crypto investment in 2026?

Pepeto and Hyperliquid serve different investment profiles in 2026. Hyperliquid at $30.73 targets $40 to $90 by year end, representing 30 to 193 percent upside for existing holders. Pepeto at $0.000000186 targets 537x from its presale floor to the $0.0001 post listing price, with three confirmed DeFi products announced by the PEPE founders approaching launch. For maximum return potential before the presale window closes, Pepeto is the stronger choice.

Comments
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09